Ethical Aspects of Prevention

Within the very large area of ethical concerns, the following issues are considered in this paper: (i) intellectual and career-oriented ambition, combined with the pressure that the competition for funds exerts, may push certain scientists to make dubious compromises with their conscience; (ii) exag...

Full description

Saved in:
Bibliographic Details
Published in:Scandinavian Journal of Work, Environment ＆ Health Environment ＆ Health, 1995-08, Vol.21 (4), p.245-251
Main Author: Tomatis, Lorenzo
Format: Article
Language:English
Subjects:
Anticarcinogenic Agents - therapeutic use
Biological and medical sciences
Breast Neoplasms - prevention & control
Cancer
Clinical Trials as Topic
Ethical justification
Ethics, Medical
Experimentation
Human experimentation
Humans
Information Dissemination
Informed Consent
Internationality
Lung Neoplasms - prevention & control
Medical sciences
Miscellaneous
Primary Prevention
Professional ethics
Public health
Public health. Hygiene
Public health. Hygiene-occupational medicine
Research - trends
Reviews
Risk Assessment
Scientific ethics
Tamoxifen - therapeutic use
Teaching. Deontology. Ethics. Legislation
Tobacco smoking
Tumors
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Within the very large area of ethical concerns, the following issues are considered in this paper: (i) intellectual and career-oriented ambition, combined with the pressure that the competition for funds exerts, may push certain scientists to make dubious compromises with their conscience; (ii) exaggerated priority is sometimes given to the smooth running of a trial, even at the cost of ignoring some ethical requirements; (iii) it is questionable whether preventive intervention can adequately and systematically replace primary prevention based on the cessation of exposure to carcinogens; (iv) it is of the utmost importance to ensure that preventive treatment that is to be administered for long periods has no adverse effects or that the benefits by far outweigh the possible risks; (v) the informed consent of participants to the trials is essential and it should be obtained on the basis of correct, complete and clear information; (vi) a different type of informed consent is that of all citizens with regard to risks to which they may be exposed voluntarily or involuntarily; (vii) there is no justification for, and it is profoundly unethical to omit, delay, or hide information that may be relevant to the protection of health. Four examples were chosen to illustrate the preceding points.
ISSN:0355-3140
1795-990X
DOI:10.5271/sjweh.33